All of 23andMe's independent directors resigned from its board this week, a rare move that marks the latest challenge for the genetic-testing company.The resignations follow drawn-out negotiations with 23andMe CEO and co-founder Anne Wojcicki, who wants to take the company private.
23andMe, which went public in 2021, has struggled to find a profitable business model since. The company reported a net loss of $667 million for its last fiscal year, more than double the loss of $312 million for the year prior.Shares for 23andMe have also plummeted — with the company's stock closing at 33 cents Thursday, down more than 97% since its 2021 stock market debut, according to FactSet.
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
23andMe board resigns in feud over CEO Anne Wojcicki's plan to take company privateThe board resignations followed CEO Anne Wojcicki’s latest proposal to take the company private.
Sumber: nypost - 🏆 91. / 67 Baca lebih lajut »
23andMe directors resign as the CEO of the genetic-testing company seeks to take it privateAll of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the genetic-testing company.
Sumber: ksatnews - 🏆 442. / 53 Baca lebih lajut »
23andMe directors resign as the CEO of the genetic-testing company seeks to take it privateAll of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the genetic-testing company. The resignations follow drawn-out negotiations with 23andMe CEO and co-founder Anne Wojcicki who wants to take the company private.
Sumber: AP - 🏆 728. / 51 Baca lebih lajut »
23andMe directors resign as the CEO of the genetic-testing company seeks to take it privateAll of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the genetic-testing company.
Sumber: wjxt4 - 🏆 246. / 63 Baca lebih lajut »